Abstract:Ischemic stroke is associated with high mortality and morbidity rates worldwide. However, the molecular mechanisms underlying the neuronal damage incurred by stroke victims remain unclear. It has previously been reported that ischemic stroke can induce an increase in the levels of brain iron, which is an important factor of in the associated brain damage. Ferroportin 1 (FPN1), the only known cellular iron export protein, is found in brain microvascular endothelial cells (BMVECs) at the blood-brain barrier, and is considered the gateway for entry of plasma iron into the central nervous system. Despite the connection of brain iron to neuronal damage, the role of BMVECs FPN1 in ischemic stroke remains unexplored. Herein, we conditionally deleted Fpn1 in mouse endothelial cells (ECs), using VE-cadherin-Cre transgenic mice, and explored the impact on brain iron homeostasis after stroke. Our data demonstrated that Fpn1 knockout in ECs decreased the brain iron levels in mice, attenuated the oxidative stress and inflammatory responses after stroke, and inhibited both ferroptosis and apoptosis, ultimately alleviating neurological impairment and decreasing cerebral infarct volume during the acute phase of ischemic stroke. By contrast, we found that Fpn1 knockout in ECs delayed the recovery of neurological function in mice following ischemic stroke. We also found that ECs Fpn1 knockout decreased the brain iron levels after stroke, exacerbated glial cell proliferation, and inhibited neuronal development, indicating that the diminished brain iron levels hindered the repair of neural injury in mice. In conclusion, our findings reveal a dual consequence of FPN1 deficiency in ECs in the development of ischemic stroke. More specifically, iron deficiency initially exerts a neuroprotective effect during the acute phase of ischemic stroke but inhibits recovery during the later stages. Our findings are important to the development of iron- or FPN1-targeting therapeutics for the treatment of ischemic stroke.

Iron Loading Inhibits Ferroportin1 Expression in Pc12 Cells

Expression and Function of Ferroportin 1 in O-2a Progenitor Cells

Iron regulates the expression of ferroportin 1 in the cultured hFOB 1.19 osteoblast cell line.

Expression of the iron transporter ferroportin in synaptic vesicles and the blood–brain barrier

Brain iron deficiency and affected contextual fear memory in mice with conditional Ferroportin1 ablation in the brain

Expression of ferroportin1, hephaestin and ceruloplasmin in rat heart

Ceruloplasmin expression and its role in iron transport in C6 cells

The cardinal roles of ferroportin and its partners in controlling cellular iron in and out

Iron-responsive miR-485-3p regulates cellular iron homeostasis by targeting ferroportin

Expression of Ferroportin 1 in Cultured Osteoblast Hfob1.19 under Iron Excess and Deficiency

Minimal Effect of Conditional Ferroportin KO in the Neural Retina Implicates Ferrous Iron in Retinal Iron Overload and Degeneration.

Lead-induced Iron Overload and Attenuated Effects of Ferroportin 1 Overexpression in PC12 Cells.

RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation

Cdh5-mediated Fpn1 deletion exerts neuroprotective effects during the acute phase and inhibitory effects during the recovery phase of ischemic stroke

Inhibition of Rab8A Protein Expression in Nerve Cells by Iron Overload

Structural Basis of Ion Transport and Inhibition in Ferroportin

Iron regulatory protein 1 outcompetes iron regulatory protein 2 in regulating cellular iron homeostasis in response to nitric oxide

NUPR1 is a critical repressor of ferroptosis

Physiological functions of Ferroportin in the regulation of renal iron recycling and ischemic acute kidney injury.

Cardiomyocyte-specific overexpression of FPN1 diminishes cardiac hypertrophy induced by chronic intermittent hypoxia

Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice